KOCAA
AMED

Knights of Columbus Asset Advisors’s Amedisys AMED Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-36,280
Closed -$8.89M – 305
2021
Q2 		$8.89M Buy
36,280
+4,188
+13% +$1.1M 0.82% 15
2021
Q1 		$8.5M Sell
32,092
-1,454
-4% -$410K 0.83% 11
2020
Q4 		$9.84M Buy
33,546
+14,915
+80% +$3.82M 1.05% 7
2020
Q3 		$4.41M Buy
18,631
+1,190
+7% +$271K 0.55% 44
2020
Q2 		$3.46M Sell
17,441
-6,876
-28% -$1.28M 0.42% 65
2020
Q1 		$4.46M Sell
24,317
-6,832
-22% -$1.22M 0.56% 39
2019
Q4 		$5.2M Buy
+31,149
New +$4.63M 0.46% 44

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Knights of Columbus Asset Advisors's AMED Position: Q3 2021 in Review

Knights of Columbus Asset Advisors sold out of Amedisys (AMED) in Q3 2021, closing a stake of 36,280 shares — an estimated $8.89M sold.

Knights of Columbus Asset Advisors first reported a position in AMED in Q4 2019 and held it in 7 quarters. The position peaked at $9.84M in Q4 2020. 352 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Knights of Columbus Asset Advisors reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 36,280 Amedisys shares in Q3 2021, an estimated $8.89M.
  • Knights of Columbus Asset Advisors first reported a position in Amedisys in Q4 2019 and held it in 7 quarters.
  • Knights of Columbus Asset Advisors's Amedisys position peaked at $9.84M in Q4 2020.
  • 352 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Knights of Columbus Asset Advisors's 13F filing for Q3 2021, filed 10 Nov 2021.